The Jonsson Comprehensive Cancer Center (JCCC) is a cancer research center at University of California, Los Angeles.
The Jonsson Comprehensive Cancer Center (JCCC) is a cancer research center at University of California, Los Angeles.
The center was originated by UCLA scientists and volunteers who began working together in the late 1960s. [1] The center was formally established in 1974 and was designated as a comprehensive cancer center by the National Cancer Institute in 1976. [1] [2] The namesake of the center is the Jonsson family; entrepreneur and philanthropist Kenneth Alan Jonsson (the son of Texas Instruments co-founder J. Erik Jonsson), along with his wife Diana Gordon Jonsson, made a $1 million gift for UCLA in 1975 to establish the center, and continued to financially support the center over a period of decades. [3] [4]
Joseph W. Cullen served as a deputy director of the center. [5]
The primary sponsor of the center is the Jonsson Cancer Center Foundation (JCCF), [2] a 501(c)(3) entity (established in 1945). [6]
The center employs over 500 physicians and scientists, who engage in clinical activities (i.e., cancer treatment), education, research (basic and clinical), and cancer prevention. [1] [2] [7]
Although based at UCLA, the center has clinics elsewhere in California, in Westwood, Santa Monica, Alhambra, Irvine, Pasadena, Porter Ranch, Santa Clarita, and Simi Valley. [2]
The center is known for its research on breast and ovarian cancer. [2] JCCC scientists developed palbociclib (PD 0332991), a breast-cancer drug that was in phase III clinical trials as of 2015. [2] JCCC scientists also identified IGF-1 as a pathway as one pathway for the growth of tumors. [2]
In 2013, U.S. News & World Report ranked JCCC as #11 nationally among cancer centers. [2] In 2015, the center ranked #6. [8]
In 2023, U.S. News & World Report ranked JCCC #4 nationally and #1 in California among cancer centers. [9]
Cedars-Sinai Medical Center is a nonprofit, tertiary, 886-bed teaching hospital and multi-specialty academic health science center located in Los Angeles, California. Part of the Cedars-Sinai Health System, the hospital has a staff of over 2,000 physicians and 10,000 employees, supported by a team of 2,000 volunteers and more than 40 community groups. As of 2022–23, U.S. News & World Report ranked Cedars-Sinai among the top performing hospitals in the western United States. Cedars-Sinai is a teaching hospital affiliate of David Geffen School of Medicine at the University of California, Los Angeles (UCLA), which was ranked in the top 20 on the U.S. News 2023 Best Medical Schools: Research.
The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.
Children's Hospital Los Angeles (CHLA) is a nationally ranked, freestanding acute care children's hospital in the East Hollywood district of Los Angeles, on Sunset Boulevard at the corner of Vermont Avenue. The hospital has been academically affiliated with the Keck School of Medicine of the University of Southern California since 1932 and the hospital features 401 pediatric beds. The hospital provides comprehensive pediatric specialties and subspecialties to infants, children, teens, and young adults generally aged 0–21 throughout California and the west coast. The hospital also sometimes treats adults that require pediatric care. The hospital has a rooftop helipad and is an ACS verified level I pediatric trauma center, one of a few in the region. The hospital features a regional pediatric intensive-care unit and an American Academy of Pediatrics verified level IV neonatal intensive care unit.
JCCC may refer to:
NCI-designated Cancer Centers are a group of 72 cancer research institutions in the United States supported by the National Cancer Institute.
The University of California, Los Angeles School of Medicine also known as the David Geffen School of Medicine at UCLA (DGSOM)—is an accredited medical school located in Los Angeles, California, United States. The school was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds. Founded in 1951, it is the second medical school in the University of California system, after the UCSF School of Medicine.
The University of California San Diego School of Medicine is the graduate medical school of the University of California, San Diego, a public land-grant research university in La Jolla, California. It was the third medical school in the University of California system, after those established at UCSF and UCLA, and is the only medical school in the San Diego metropolitan area. It is closely affiliated with the medical centers that are part of UC San Diego Health.
City of Hope is a private, non-profit clinical research center, hospital and graduate school located in Duarte, California, United States. The center's main campus resides on 110 acres (45 ha) of land adjacent to the boundaries of Duarte and Irwindale, with a network of clinical practice locations throughout Southern California, satellite offices in Monrovia and Irwindale, and regional fundraising offices throughout the United States.
Harbor–UCLA Medical Center, is a 570-bed public teaching hospital located at 1000 West Carson Street in West Carson, an unincorporated area within Los Angeles County, California. The hospital is owned by Los Angeles County and operated by the Los Angeles County Department of Health Services, while doctors are faculty of the David Geffen School of Medicine at UCLA, who oversee the medical residents being trained at the facility.
Dennis Joseph Slamon, is an American oncologist and chief of the division of Hematology-Oncology at UCLA. He is best known for his work identifying the HER2/neu oncogene that is amplified in 25-33% of breast cancer patients and the resulting treatment trastuzumab.
Joseph W. Cullen was an American cancer prevention and rehabilitation researcher and briefly director of the AMC Cancer Research Center (1989-1990). He previously worked at the VA Hospital in Maryland (1968-1973), the National Institutes of Health (1973), the National Cancer Institute (NCI), and the Jonsson Comprehensive Cancer Center (1976-1982), holding high-level positions such as division director at several. He was a coordinator, creator, and researcher for the Smoking Tobacco and Cancer Program at the NCI, the largest anti-smoking campaign in the world at that time. Cullen wrote more than 90 publications in his lifetime, including four books.
The Noreen Fraser Foundation (NFF) was a national, non-profit, philanthropic organization based in Los Angeles. Its mission was to raise funds for breakthrough research that advances precision medicine for the prevention and treatment of women's cancers. Their hope was that the cancer will become a manageable disease that patients will live with and not die from, until it ceases to exist.
Susan Margaret Love was an American surgeon, a prominent advocate of preventive breast cancer research, and author. She was regarded as one of the most respected women's health specialists in the United States. Love is best known for pioneering work fueled by her criticism of the medical establishment's paternalistic treatment of women. She was an early advocate of cancer surgery that conserves as much breast tissue as possible. She also was among the first to sound the alarm on the risks of routine hormone replacement therapy (HRT) for menopausal women.
Alan Ashworth, FRS is a British molecular biologist, noted for his work on genes involved in cancer susceptibility. He is currently the President of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, a multidisciplinary research and clinical care organisation that is one of the largest cancer centres in the Western United States. He was previously CEO of the Institute of Cancer Research (ICR) in London.
Ronald Reagan UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles (UCLA), in Westwood, Los Angeles, California, United States. It is currently ranked the fifth-best hospital in the United States by U.S. News & World Report, and second best in California and the West Coast. The hospital provides tertiary care to Los Angeles and the surrounding communities.
James S. Economou is an American physician-scientist on the faculty of the University of California, Los Angeles (UCLA) where he is also a surgical oncologist and tumor immunologist. He was Vice Chancellor for Research at UCLA (2010-2015) where he promoted academic entrepreneurship, transdisciplinary research, and support of the humanities, arts, and social sciences. The UCLA research enterprise generates almost one billion dollars in extramural funds annually.
UCLA Health is a health system which comprises a number of hospitals, the David Geffen School of Medicine at UCLA and an extensive primary care network in the Los Angeles region. As a regional health provider, it benefits from the academic affiliation offered by the UCLA campus, as this increases its status in the medical marketplace. For instance, the symbiotic relationship with the campus allowed the creation of nominal assistant professor-level appointments for primary care physicians, but this practice has now been limited because of opposition from the academic community.
Kathryn Ferguson Fink was an American biochemist known for her work in nuclear medicine, particularly in the use of radiolabeling to study metabolism. Fink spent most of her career at the University of California, Los Angeles, often collaborating with her fellow biochemist husband Robert Morgan Fink, and was the first Ph.D. to become a Professor of Medicine at the UCLA School of Medicine. She died of cancer in 1989.
Saul Brandman was an American businessman and philanthropist.
Patricia Anne Ganz is an American medical oncologist. She is a professor of health policy and management in the Fielding School of Public Health and a professor of medicine in the David Geffen School of Medicine at UCLA. In 2007, she was elected to the Institute of Medicine.